Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,287 | 57,002 | 44,257 | 4,910 | 40,912 |
| Marketable Securities | 39,811 | 25,451 | N/A | N/A | N/A |
| Receivables | 324 | 544 | 1,827 | 133 | 321 |
| TOTAL | $62,947 | $83,976 | $47,076 | $5,698 | $42,404 |
| Non-Current Assets | |||||
| PPE Net | 10,832 | 11,489 | 13,567 | 1,918 | 13,968 |
| Intangibles | 35,801 | 38,944 | 2,473 | 1,033 | 5,108 |
| Other Non-Current Assets | 363 | 5,955 | 6,677 | 725 | 0 |
| TOTAL | $46,996 | $56,388 | $22,717 | $3,676 | $19,076 |
| Total Assets | $109,943 | $140,364 | $69,793 | $9,375 | $61,480 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 13,523 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 931 | 1,445 | 5,111 | 6,586 | 2,552 |
| Accrued Expenses | 4,936 | 5,615 | 3,841 | 2,519 | 2,675 |
| Other current liabilities | 818 | 2,156 | 218 | 57 | 478 |
| TOTAL | $20,208 | $14,407 | $14,101 | $10,136 | $10,084 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,889 | N/A | N/A | N/A | N/A |
| Deferred Revenues | N/A | 5,191 | 4,931 | 974 | 4,380 |
| Other Non-Current Liabilities | 5,591 | 17,999 | 1,069 | 150 | 4,165 |
| TOTAL | $14,480 | $52,190 | $37,558 | $370 | $49,234 |
| Total Liabilities | $34,688 | $66,597 | $51,659 | $10,506 | $59,319 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,138 | 2,115 | 1,055 | 996 | 412 |
| Common Shares | 32 | 32 | 16 | 8 | 6 |
| Retained earnings | -160,207 | -157,674 | -121,149 | -73,649 | -256,246 |
| Other shareholders' equity | 2,751 | 2,546 | 2,606 | 2,619 | -228 |
| TOTAL | $75,255 | $73,767 | $18,134 | $-1,132 | $2,161 |
| Total Liabilities And Equity | $109,943 | $140,364 | $69,793 | $9,375 | $61,480 |